Keryx Biopharmaceuticals (KERX) March & April straddle suggests risk into results

March 7, 2008 7:29 AM EST Send to a Friend
Keryx Biopharmaceuticals (Nasdaq: KERX) : KERX lead compound, Sulonex (sulodexide oral gelcap), is a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login